Combined effects of chuling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer.

  • J. S. You*
  • , D. M. Hau
  • , K. T. Chen
  • , H. F. Huang
  • *Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

28 Scopus citations

Abstract

Chuling (Polyporus umbellatus), one of the commonly used Chinese medical herbs, was combined with mitomycin C and then studied against intrahepatic implantation of sarcoma 180 tumor cells in mice. Oral administration of chuling extract, intraperitoneal injection of mitomycin C and the combination of both increased the life span of tumor-bearing mice 71.6%, 70.1% and 119.9%, respectively. The same treatments were found to be cytotoxic to Sarcoma-180-induced liver tumor cells. The synthetic rates of DNA, RNA and protein were all inhibited measurably by the combined treatment. Histopathological studies showed that lymphocytes infiltrated and surrounded the cancer cells, and there was some fibrosis found in normal cells and cancer cells. These results indicate the potential use of chuling as an anticancer agent.

Original languageEnglish
Pages (from-to)19-28
Number of pages10
JournalAmerican Journal of Chinese Medicine
Volume22
Issue number1
DOIs
StatePublished - 1994
Externally publishedYes

Fingerprint

Dive into the research topics of 'Combined effects of chuling (Polyporus umbellatus) extract and mitomycin C on experimental liver cancer.'. Together they form a unique fingerprint.

Cite this